ABSTRACT
Yeasts respond to treatment with azoles and other sterol biosynthesis inhibitors by upregulating the expression of the
ERG
genes responsible for ergosterol production. Previous studies on
Saccharomyces cerevisiae
implicated the
ROX1
repressor in
ERG
regulation. We report that
ROX1
deletion resulted in 2.5- to 16-fold-lower susceptibilities to azoles and terbinafine. In untreated cultures,
ERG11
was maximally expressed in mid-log phase and expression decreased in late log phase, while the inverse was observed for
ROX1
. In azole-treated cultures,
ERG11
upregulation was preceded by a decrease in
ROX1
RNA. These inverse correlations suggest that transcriptional regulation of
ROX1
is an important determinant of
ERG
expression and hence of azole and terbinafine susceptibilities.